# Evaluation of The Efficacy of Triazavirin Versus Oseltamivir in Egyptian Patients Infected With COVID-19

> **NCT04973462** · PHASE4 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 80 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** standard treatment COVID-19 + Triazavirin

## Key facts

- **NCT ID:** NCT04973462
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-01
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04973462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04973462, "Evaluation of The Efficacy of Triazavirin Versus Oseltamivir in Egyptian Patients Infected With COVID-19". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT04973462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*